You are here

Cordlife's 'belle of the ball' in bid for China Cord Blood

Takeover bid for US-listed China Cord Blood Corp shines spotlight on its substantial shareholder Singapore's Cordlife

jiacor3543.jpg
A takeout offer for a major China cord blood firm listed on the New York Stock Exchange is firing up interest in its substantial shareholder Singapore-listed Cordlife Group with expectations that it too may be a target in the bid to control China Cord Blood Corp (CCBC).

Singapore

A TAKEOUT offer for a major China cord blood firm listed on the New York Stock Exchange is firing up interest in its substantial shareholder Singapore-listed Cordlife Group with expectations that it too may be a target in the bid to control China Cord Blood Corp (CCBC).

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom